Milly Gaines
Diet pills, also known as appetite suppressants, are a type of weight-loss medication for people with obesity. They work by reducing appetite or creating a feeling of fullness after eating smaller amounts of food. While these drugs can be effective in helping people lose weight, there are concerns about their potential impact on mental health and the risk of side effects such as depression and anxiety. Some studies have found a link between certain weight loss drugs and an increased risk of depression and suicidal thoughts, while others have not found a significant association. The exact relationship between diet pills and depression remains a subject of ongoing research, with healthcare professionals emphasizing the need to be aware of potential risks while also considering individual patient needs and confounding factors.
| Characteristics | Values |
|---|---|
| Types of diet pills | Appetite suppressants, stimulants, lipase inhibitors, GLP-1 receptor agonists |
| Appetite suppressants | Affect how the body and brain experience appetite and hunger, making people feel less hungry or full faster |
| Examples of appetite suppressants | Liraglutide (Saxenda), Semaglutide (Wegovy), Naltrexone-bupropion (Contrave), Phentermine-topiramate (Qsymia) |
| Side effects of appetite suppressants | Mood changes, nausea and vomiting, diarrhoea or constipation, abdominal pain, insomnia, increased blood pressure, fast heart rate, drug dependence, withdrawal symptoms |
| Stimulants | Phentermine (Adipex-P) |
| Side effects of stimulants | Insomnia, increased blood pressure, fast heart rate, restlessness, drug dependence, abuse, withdrawal symptoms |
| Lipase inhibitors | Orlistat (Alli or Xenical) |
| Side effects of lipase inhibitors | Rare liver injury, itching, yellow skin or eyes (jaundice), stomach pain, loss of appetite, pale or tar-coloured stools, brown-coloured urine |
| GLP-1 receptor agonists | Liraglutide (Saxenda), Semaglutide (Wegovy, Ozempic), Tirzepatide (Zepbound, Mounjaro) |
| Side effects of GLP-1 receptor agonists | Diarrhoea, upset stomach (nausea or vomiting), heartburn, gas or constipation |
| Other diet pills | Bupropion and naltrexone (Contrave), Sibutramine, Phenylethylamine agents, Non-phenylethylamine psychostimulants (e.g. caffeine), Fenfluramine |
| Side effects of other diet pills | Headache, dry mouth, dizziness, nausea, vomiting, constipation, liver damage, suicidal thoughts and actions, mania, psychosis, hallucinations, paranoia, delusions |
| Potential causes of depression | Influence on brain chemistry, decreased dopamine release, confounding factors such as underlying health conditions |
| Studies on the link between diet pills and depression | No substantial evidence linking modern weight loss drugs like sibutramine and orlistat to depression, ongoing research into the link between diet pills and mental health |
Explore related products
$9.42
What You'll Learn
- Appetite suppressants, such as Liraglutide, can cause mood changes, including depression and anxiety
- Bupropion, an antidepressant, has been linked to serious psychiatric side effects, including depression and mania
- GLP-1 receptor agonists, like Liraglutide, can cause nausea, vomiting, and other stomach issues
- Stimulant-type drugs, e.g. Phentermine, may lead to insomnia, increased blood pressure, and drug dependence
- Orlistat, a lipase inhibitor, can cause rare liver injury and patients should watch for signs of liver disease
Appetite suppressants, such as Liraglutide, can cause mood changes, including depression and anxiety
Appetite suppressants are a type of weight-loss medication, also known as diet pills, for people with obesity (a body mass index, or BMI, over 30). They work by affecting how the body and brain experience appetite and hunger. Appetite suppressants can make you feel less hungry or make you feel full faster after eating less food, which results in reduced calorie intake and weight loss.
Some appetite suppressants can interact with medications, including antidepressants and anti-anxiety drugs. They can also worsen certain health conditions, such as high blood pressure, mood disorders, and glaucoma. It is important to consult a healthcare provider before taking appetite suppressants to discuss potential side effects and risks.
Liraglutide is a prescription appetite suppressant approved by the Food and Drug Administration (FDA) for long-term use. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications used to treat Type 2 diabetes by reducing appetite and promoting weight loss. While GLP-1 receptor agonists have been shown to be effective in weight management, there have been reports of negative mood changes associated with their use.
Recent studies have identified potential psychiatric adverse events associated with liraglutide, including depression, anxiety, and suicidal ideation. In randomized controlled trials of liraglutide, there was a slight numerical imbalance in suicidal ideation reports. Additionally, an analysis of case safety reports submitted to the EudraVigilance database revealed a high number of adverse event reports for liraglutide, with 16,748 reports, of which 372 were psychiatric adverse events.
Healthcare professionals should be aware of the potential psychiatric adverse events associated with liraglutide and other GLP-1 receptor agonists. Patients should be encouraged to report any changes in mood or behavior and be screened for pre-existing psychiatric conditions. While these medications can be effective for weight loss, the decision to prescribe them should be made on a case-by-case basis, carefully weighing the risks and benefits.
Carb Counting: Keno Diet's Carb Allowance Explained
You may want to see also
Explore related products
Bupropion, an antidepressant, has been linked to serious psychiatric side effects, including depression and mania
Bupropion is an antidepressant medication that has been approved by the FDA to treat major depressive disorder (MDD) and seasonal affective disorder (SAD). It is also used to aid smoking cessation and treat attention deficit hyperactivity disorder (ADHD). Bupropion is sometimes prescribed off-label for various conditions, including antidepressant-induced sexual dysfunction, depression associated with bipolar disorder, obesity, and ADHD in paediatric patients.
Bupropion interacts with several medications, including antidepressants, clopidogrel, and drugs that lower the seizure threshold. It is essential to consult a doctor before taking bupropion, especially if one is already taking medication for depression or smoking cessation. Bupropion should be used cautiously in patients with chronic liver disease (CLD) and renal impairment, and dose adjustments are necessary for these populations.
While bupropion can be effective in treating depression, it has been associated with serious psychiatric side effects. These side effects can occur even in adults without a history of mental illness. Patients taking bupropion should be monitored for adverse reactions, and their families or caregivers should be educated about the potential risks. If any of the following symptoms occur, patients should stop taking bupropion and seek immediate medical attention:
- Suicidal thoughts or actions
- New or worsening depression, anxiety, or panic attacks
- Agitation
- Restlessness
- Angry or violent behaviour
- Acting dangerously
- Mania (abnormally excited or irritated mood)
- Abnormal thoughts or sensations
- Hallucinations (seeing or hearing things that are not there)
- Paranoia (feeling that people are against you)
- Confusion
- Insomnia
- High blood pressure
- Severe skin reactions (e.g., Stevens-Johnson syndrome)
- Seizures
- Drowsiness, dizziness, or decreased alertness
Diet Adjustments for a Less Greasy Complexion
You may want to see also
Explore related products
GLP-1 receptor agonists, like Liraglutide, can cause nausea, vomiting, and other stomach issues
A range of medications used to aid weight loss have been associated with the onset or worsening of depressive symptoms and disorders. These include a large number of phenylethylamine agents with psychostimulant properties, non-phenylethylamine psychostimulants (e.g. caffeine), and the serotonergic agent, fenfluramine. However, there is no substantial evidence linking modern weight loss drugs like sibutramine and orlistat to major depression.
GLP-1 receptor agonists, such as Liraglutide, are a type of weight-loss medication that can cause nausea, vomiting, and other stomach issues. They are typically used for the treatment of type 2 diabetes and obesity due to their effectiveness in controlling glycaemia and inducing weight loss. While these drugs are generally well-tolerated, they can lead to gastrointestinal adverse events (GI AEs) in 40-70% of patients, with some reports of up to 85%. These side effects include nausea, vomiting, diarrhoea, constipation, and, less commonly, pancreatitis and gastroparesis.
To manage nausea, individuals can avoid strong smells and consume crackers, mint, or ginger-based foods or drinks about half an hour after taking a GLP-1 drug. Vomiting can be managed by staying hydrated and consuming smaller, more frequent meals. Diarrhoea can be alleviated by increasing water intake and avoiding dairy and high-fibre foods until symptoms subside. It is important to stay well-hydrated when experiencing diarrhoea to prevent dehydration. To relieve constipation, individuals should increase their fibre intake and fluid consumption.
It is worth noting that long-acting GLP-1 receptor agonists tend to cause less nausea and vomiting but more diarrhoea. Additionally, flatulence may occasionally occur as a side effect. These gastrointestinal side effects are usually transient, starting during the dose-escalation period and resolving shortly after reaching the maintenance dose. They are typically mild to moderate in severity and can be minimised by following specific guidelines provided by healthcare professionals.
While GLP-1 receptor agonists can effectively induce weight loss, individuals should be aware of the potential for gastrointestinal adverse events and take appropriate measures to prevent or mitigate these side effects. It is always important to consult with a healthcare provider before starting any new medication to ensure a comprehensive understanding of the benefits and risks involved.
Sudden Diet Changes: Intestinal Distress Culprit?
You may want to see also
Explore related products
Stimulant-type drugs, e.g. Phentermine, may lead to insomnia, increased blood pressure, and drug dependence
Phentermine is a stimulant drug that can cause nervousness, irritability, insomnia, and a racing heart. It is typically prescribed to patients with a body mass index (BMI) of 30 kg/m2 or greater. It may also be prescribed to people with a BMI of 27 kg/m2 or greater with other risk factors, such as high blood pressure, diabetes, or high cholesterol. Phentermine is meant to be used in the short term, for 12 weeks or less, in conjunction with exercise, behavioural modification, and caloric restriction.
Phentermine is a stimulant that can raise your heart rate and blood pressure. It is generally safe to take phentermine with high blood pressure medications, but only if your blood pressure is well-managed with medication. Phentermine should not be taken with other weight loss drugs, as it can cause a rare fatal lung disorder called pulmonary hypertension. Taking phentermine with other stimulant medications can also increase the risk of serious side effects, including high blood pressure, rapid heart rate, anxiety, insomnia, and, in severe cases, heart attack or stroke.
Phentermine may also interact with diabetes medications, as it can reduce appetite and food intake, which lowers blood sugar levels. Doctors will closely monitor blood sugar levels and adjust diabetes medication if necessary. Phentermine may also interact with caffeine, as consuming too much caffeine while taking phentermine can increase the risk of side effects, including nervousness, headaches, or insomnia.
Long-term use of phentermine, or treatment of more than a few weeks, increases the risk of addiction and dependence. Doctors will not prescribe phentermine to patients with agitation, as it can worsen those feelings. Phentermine should also not be prescribed in combination with a type of antidepressant called a monoamine oxidase inhibitor (MAOI), as it can increase blood pressure and lead to a hypertensive crisis.
Kick the Diet Dr Pepper Habit for Good
You may want to see also
Explore related products
Orlistat, a lipase inhibitor, can cause rare liver injury and patients should watch for signs of liver disease
A variety of medications used to assist with weight loss have been linked to the precipitation or induction of depressive symptoms and disorders. However, there is currently no substantial evidence linking the more modern weight-loss drugs, sibutramine and orlistat, to major depression. Nevertheless, major depression remains an important clinical consideration when using these drugs due to the elevated frequency of major depression in obese patients and the interplay between symptoms of depression and weight loss treatment.
Orlistat is a lipase inhibitor and a commonly used weight-loss agent available by prescription or over the counter. It inhibits the digestion of dietary fats and prevents their absorption, reducing caloric intake. While orlistat is generally considered safe and effective, there have been rare cases of severe liver injury associated with its use. The onset of liver injury typically occurs between 2 and 12 weeks after starting orlistat treatment. Some cases have been severe, resulting in hepatic failure, progression to death, or the need for liver transplantation. Clinicians should be aware of the potential risk of liver injury when prescribing orlistat and carefully monitor patients taking this medication for signs of hepatic dysfunction.
It is important to note that orlistat may not be the only factor contributing to liver injury. Confounding factors, such as underlying health conditions, could also play a role. Additionally, the exact mechanism of hepatotoxicity is not yet fully understood. While some cases have been attributed to an immunoallergic reaction, the absence of alternative explanations and the improvement of liver function after discontinuing orlistat suggest that the drug may be a contributing factor in rare cases of liver injury.
As with any medication, it is crucial to consult a healthcare provider before taking orlistat to ensure it is safe and appropriate for your individual needs. They can advise on potential side effects, interactions with other medications, and any specific precautions or contraindications. By working closely with a healthcare provider, individuals can make informed decisions about their treatment options and ensure their safety while pursuing their health goals.
Sugar Glider Diet: What, When, and How to Feed
You may want to see also
Frequently asked questions
Diet pills, also known as appetite suppressants, are a type of weight-loss medication for people with obesity (a body mass index or BMI of over 30). They work by lessening your appetite or making you feel full faster.
Some diet pills have been linked to depression and other psychiatric side effects. For example, Bupropion, an antidepressant, has been associated with mood changes, mania, psychosis, hallucinations, paranoia, delusions, and thoughts of suicide. However, there is currently no substantial evidence linking modern weight loss drugs like sibutramine and orlistat to major depression.
Diet pills can cause a range of side effects, including insomnia, increased blood pressure, a fast heart rate, restlessness, drug dependence, abuse, and withdrawal symptoms, dizziness, constipation, dry mouth, nausea, and vomiting.
If you experience any side effects from taking diet pills, it is important to contact your healthcare provider immediately. They will be able to advise you on the best course of action and provide alternative treatment options if necessary.
